Display options
Share it on

Urol Ann. 2017 Apr-Jun;9(2):145-149. doi: 10.4103/UA.UA_95_16.

Management of renal caliceal diverticular stones: A decade of experience.

Urology annals

Madhusudan Patodia, Rahul Janak Sinha, Siddharth Singh, Vishwajeet Singh

Affiliations

  1. Department of Urology, Narayana Multispeciality Hospital, Jaipur, Rajasthan, India.
  2. Department of Urology, King George's Medical University, Lucknow, Uttar Pradesh, India.

PMID: 28479765 PMCID: PMC5405657 DOI: 10.4103/UA.UA_95_16

Abstract

OBJECTIVE: The objective of this study is to evaluate our methods for management of renal caliceal diverticular stones (CDS).

MATERIALS AND METHODS: We conducted a retrospective study from January 2005 to July 2015 and included patients who were treated for renal CDS. Patients were evaluated for treatment modality, puncture site (in case percutaneous nephrolithotomy [PCNL] attempted), operative time, stone clearance rate, and complications. During PCNL, if the infundibulum was found to connect the diverticulum to the calyx, then a double J stent was placed. No attempt was made to dilate the diverticular neck or to create a neoinfundibulum.

RESULTS: Twenty-four patients were treated for CDS during the study period. Two patients underwent shockwave lithotripsy, and 22 were managed by PCNL. Mean stone size was 16.37 mm (range: 6-35 mm) and mean diverticulum size was 20.62 mm (range: 12-37 mm). No fulguration was done in initial 17 patients, while fulguration by Holmium Laser was performed in the last five cases treated with PCNL. Mean operative time was 70.31 min (range: 47-90 min). Mean follow-up was 34 months, diverticulum resolved in 14 patients and reduced in size in 7 patients.

CONCLUSION: Caliceal diverticular calculi can be treated most efficiently by PCNL. Stone-guided puncture and no attempt to dilate or create neoinfundibulum reduces operative time and morbidity while yielding high stone-free rate.

Keywords: Caliceal diverticular stone; caliceal diverticulum; percutaneous nephrolithotomy

Conflict of interest statement

There are no conflicts of interest.

References

  1. J Urol. 1994 Jan;151(1):122-4 - PubMed
  2. J Endourol. 2009 Oct;23(10):1723-9 - PubMed
  3. J Urol. 1997 Sep;158(3 Pt 1):709-13 - PubMed
  4. J Urol. 2009 Mar;181(3):1306-11; discussion 1311 - PubMed
  5. J Endourol. 1999 Mar;13(2):83-8 - PubMed
  6. Indian J Urol. 2013 Oct;29(4):273-6 - PubMed
  7. J Urol. 1986 Feb;135(2):225-7 - PubMed
  8. J Endourol. 2002 Oct;16(8):557-63 - PubMed
  9. J Vasc Interv Radiol. 2000 Jul-Aug;11(7):885-9 - PubMed
  10. J Endourol. 2011 Nov;25(11):1741-5 - PubMed
  11. Eur Urol. 2002 Apr;41(4):474-7 - PubMed
  12. J Endourol. 2006 Mar;20(3):175-8 - PubMed
  13. Urol Res. 2007 Feb;35(1):35-40 - PubMed
  14. J Urol. 2000 Jul;164(1):18-20 - PubMed
  15. J Urol. 1974 Jan;111(1):2-6 - PubMed
  16. Urology. 1993 Jul;42(1):21-5 - PubMed
  17. J Urol. 2002 Mar;167(3):1248-52 - PubMed
  18. J Urol. 1998 Nov;160(5):1635-9 - PubMed
  19. J Urol. 1991 Sep;146(3):724-7 - PubMed
  20. J Urol. 2000 Jan;163(1):28-32 - PubMed
  21. Arch Ital Urol Androl. 2000 Jun;72(2):59-63 - PubMed
  22. Br J Radiol. 2010 Oct;83(994):888-94 - PubMed

Publication Types